Endpoints News
WuXi AppTec sues the Pentagon Read in browser
Endpoints News
Thank you for reading, dupa dupackia!
basic
UPGRADE
M T W Th Fri
12 June, 2026
LGBTQ+ LEADERSHIP IN 2026
LGBTQ+ diversity drives innovation in biopharma — but transgender and non-binary professionals face rising challenges. Endpoints is going live with our fourth annual special report celebrating the honorees giving voice and visibility while forging ahead across life sciences. Join us.
presented by McKesson
De­liv­er­ing ex­cel­lence, close to home: Build­ing the in­fra­struc­ture for mod­ern com­mu­ni­ty on­col­o­gy
SPOTLIGHT
Here are biopharma’s 10 highest-paid scientists and doctors for 2025 
ENDPOINTS NEWS
Endpoints Women in Biopharma: Nominate for 2026
ENDPOINTS NEWS
news
GSK took advantage of ASCO dip to get discount on Nuvalent
ENDPOINTS NEWS
WuXi AppTec sues Pentagon in challenge over inclusion on Chinese military list
ENDPOINTS NEWS
Peer Review
Novo's M&A leader leaves for Forbion; Perrigo CEO's 'personal conduct' issues led to resignation
ENDPOINTS NEWS
AACR DRUG DISCOVERY AND DEVELOPMENT (AACR D3)
The global one-stop conference convening experts across the drug discovery and development pipeline that will reshape the future of oncology therapeutics.
sponsored by American Association for Cancer Research
PHARMA
Drugmakers are turning to logistics providers as trade disruptions linger, DHL exec says
ENDPOINTS NEWS
Exclusive: Genentech lays off top scientist Vishva Dixit, closes infectious disease research unit in restructuring
ENDPOINTS NEWS
Neion Bio lands $23M Series A to make proteins from chicken eggs
ENDPOINTS NEWS
in case you missed it
1.
Summit withdraws $500M offering, citing 'market conditions'
ENDPOINTS NEWS
2.
Kardigan's $320M IPO pitch: Three borrowed heart drugs, one proven cardio CEO
ENDPOINTS NEWS
3.
News Briefing
Sensorion axes hearing loss program; Novartis' biomarker data in muscular dystrophy
ENDPOINTS NEWS
4.
Takeda's plaque psoriasis pill beats Bristol Myers' Sotyktu in Phase 3
ENDPOINTS NEWS
5.
UK approves Novo weight-loss pill to edge open European market
REUTERS
6.
Bayer shares hinge on two court decisions after $60 billion rout
BLOOMBERG
Reynald Castaneda
.

We've got a mighty team going to the BIO convention in San Diego later this month. Feel free to say hi to Max Bayer, Ryan Cross, Andrew Dunn and Kyle LaHucik.

.
Reynald Castaneda
Deputy Editor, Endpoints News
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter